Difference between revisions of "Part:BBa K3096030:Design"
m (→Source) |
m (→References) |
||
| Line 17: | Line 17: | ||
===References=== | ===References=== | ||
Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006 | Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006 | ||
| + | |||
| + | KR 1020120130606-A/1: Secretion signal peptide linked Exendin-4 gene transduced pancreatic islet cluster for treatment of type I diabetes | ||
Revision as of 12:42, 15 October 2019
Exendin-4 (GLP-1 analogue) with secretion signal
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
no changes were made to the sequence
Source
KR 1020120130606-A/1: Secretion signal peptide linked Exendin-4 gene transduced pancreatic islet cluster for treatment of type I diabetes
References
Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006
KR 1020120130606-A/1: Secretion signal peptide linked Exendin-4 gene transduced pancreatic islet cluster for treatment of type I diabetes